000 01245nam a2200325Ia 4500
001 89190
003 BIBL
003 OCoLC
005 20191122021230.0
008 820221s1955 xx a 100 0 eng d
010 _a 55012160
019 _a00831433
_a00916786
035 _a(OCoLC)14189153
040 _aNLM
_cNLM
_dm.c.
_dOCL
_dOUN
_dSER
_dCUX
049 _aPUXA
050 0 _aRM666.C523
_bS5 1955
060 0 _aW3
_bC5695 1955
069 0 _a23720760R
082 _a616.8
111 2 0 _aConference on Chlorpromazine and Mental Health
_d(1955
_cPhiladelphia)
111 2 0 _aConference on Chlorpromazine and Mental Health
_d(1955
_cPhiladelphia)
_9212493
_2Local
111 2 0 _aConference on Chlorpromazine and Mental Health
_d(1955
_cPhiladelphia)
245 1 0 _aChlorpromazine and mental health
_bproceedings of the symposium
_cheld under the auspices of Smith, Kline & French Laboratories, June 6, 1955, Warwick Hotel, Philadelphia, Pennsylvania.
260 0 _aPhiladelphia
_bLea & Febiger
_c1955.
300 _a200 p.
_bill.
650 2 _aMental Disorders
_xcongresses.
_9135246
_2Local
650 0 _aPsychotherapy
_2Local
_9154823
650 0 _aChlorpromazine.
_9210115
_2Local
710 2 0 _aSmith, Kline & French Laboratories.
_wcn
_9171392
_2Local
999 _c72591
_d72591